학술논문
Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study
Document Type
Article
Author
Source
In Gynecologic Oncology July 2020 158(1):47-53
Subject
Language
ISSN
0090-8258